RESUMO
INTRODUCTION: the use of coracoclavicular augmentation systems together with locking plates in the treatment of unstable distal clavicle fractures (Neer II and Neer V) is controversial. MATERIAL AND METHODS: patients with unstable distal clavicle fractures treated between 2013-2022 were retrospectively reviewed. The patients were divided into two groups: patients treated with locking plates (P group) and patients treated with locking plates and coracoclavicular augmentation systems (PCC group). Postoperative complications, modified preoperative and final coracoclavicular distance (CC), and outcomes on the Visual Analog Scale (VAS) and Quick Disabilities of the Arm, Shoulder, and Hand (Quick DASH) were recorded. RESULTS: 16 of 23 patients were treated with plates only, and 7 of 23 were treated with plates and coracoclavicular augmentation systems. One case showed no fracture consolidation, and there was one case of cutaneous infection. The mean final CC distance was 23.7 in the P group and 22.1 in the PCC group. The mean VAS score was 1.3 in both the P and PCC groups, while the mean Quick DASH score was 5.5 in the P group and 8.1 in the PCC group. No significant differences were found in CC distance, VAS or Quick DASH scores. CONCLUSION: the use of locking plates is likely sufficient in the management of unstable distal clavicle fractures, as there were no significant differences in functional outcomes in this study when coracoclavicular augmentation systems were used together with locking plates.
INTRODUCCIÓN: el uso de sistemas de aumentación coracoclaviculares en combinación con placas bloqueadas en el tratamiento de las fracturas de clavícula distal inestables es controvertido. MATERIAL Y MÉTODOS: se han revisado retrospectivamente los pacientes con fracturas distales de clavícula inestables tratados entre 2013-2022 en Hospital Clínic de Barcelona. Se dividieron a los pacientes en dos grupos: pacientes tratados con placas bloqueadas (grupo P) y pacientes tratados con placas bloqueadas y sistemas de aumentación coracoclaviculares (grupo PCC). Se registraron las complicaciones postoperatorias, distancia CC (coracoclavicular) modificada preoperatoria y final, así como los resultados en la escala visual analógica (EVA) y en el Quick Disabilities of the Arm, Shoulder and Hand (Quick DASH). RESULTADOS: de un total de 23 pacientes, 16 se trataron sólo con placas y siete con placas y sistemas de aumentación coracoclaviculares. Se observó ausencia de consolidación en un caso e infección cutánea en otro. La distancia CC final media fue de 23.7 mm en el grupo P y de 22.1 mm en el grupo PCC. La media de la EVA fue de 1.3 en ambos grupos, mientras que el Quick DASH tuvo media de 5.5 en el grupo P y de 8.1 en el grupo PCC. No se encontraron diferencias significativas en la distancia CC, en la EVA ni en el Quick DASH. CONCLUSIÓN: los resultados sugieren que el uso de placas bloqueadas es probablemente suficiente en el manejo de las fracturas de clavícula distales inestables, sin observar diferencias significativas en los resultados funcionales al agregar sistemas de aumentación coracoclavicular.
Assuntos
Fixação Interna de Fraturas , Fraturas Ósseas , Humanos , Estudos Retrospectivos , Clavícula/cirurgia , Resultado do Tratamento , Placas Ósseas , Fraturas Ósseas/cirurgia , Fraturas Ósseas/etiologiaRESUMO
CASE REPORT: A 47 year-old woman with a choroidal melanoma developed a macular oedema secondary to radiation therapy 75 months after brachytherapy plaque. The patient received 3 intravitreal Bevacizumab injections. DISCUSSION: The patient had a good response to bevacizumab treatment. In fact, there was a reduction in the macular oedema measured by optical coherence tomography (OCT) scan, as well as an improvement in best corrected visual acuity. There was no recurrence of macular oedema, and visual acuity remained stable after 3-years follow-up.
Assuntos
Inibidores da Angiogênese/uso terapêutico , Bevacizumab/uso terapêutico , Braquiterapia/efeitos adversos , Neoplasias da Coroide/radioterapia , Edema Macular/tratamento farmacológico , Melanoma/radioterapia , Lesões por Radiação/tratamento farmacológico , Inibidores da Angiogênese/administração & dosagem , Bevacizumab/administração & dosagem , Hemorragia da Coroide/etiologia , Feminino , Angiofluoresceinografia , Humanos , Injeções Intravítreas , Implante de Lente Intraocular , Edema Macular/diagnóstico por imagem , Edema Macular/etiologia , Pessoa de Meia-Idade , Facoemulsificação , Complicações Pós-Operatórias/tratamento farmacológico , Complicações Pós-Operatórias/etiologia , Lesões por Radiação/diagnóstico por imagem , Lesões por Radiação/etiologia , Tomografia de Coerência ÓpticaRESUMO
CASE REPORT: The case is presented of a 49 year-old woman with an orbital mass originating from the rhinosinus. She had a history of Wegener's granulomatosis, refractory to both biological and immunosuppressive therapy. Clinical examination showed proptosis, diplopia, and restriction of ocular movements. DISCUSSION: Orbital mass resection was performed, due to its rapid growth, and lack of response to medical treatment.
Assuntos
Seio Etmoidal/diagnóstico por imagem , Granuloma/patologia , Granulomatose com Poliangiite/patologia , Cavidade Nasal/diagnóstico por imagem , Doenças Orbitárias/patologia , Terapia Combinada , Diplopia/etiologia , Progressão da Doença , Resistência a Medicamentos , Seio Etmoidal/cirurgia , Exoftalmia/etiologia , Feminino , Granuloma/complicações , Granulomatose com Poliangiite/complicações , Granulomatose com Poliangiite/tratamento farmacológico , Granulomatose com Poliangiite/cirurgia , Humanos , Imunossupressores/uso terapêutico , Pessoa de Meia-Idade , Doenças Orbitárias/diagnóstico por imagem , Doenças Orbitárias/cirurgia , Tomografia Computadorizada por Raios XRESUMO
Choline kinase (CK) is a homodimeric enzyme that catalyses the transfer of the ATP γ-phosphate to choline, generating phosphocholine and ADP in the presence of magnesium. Several isoforms of CK are present in humans but only the HsCKα has been associated with cancer and validated as a drug target to treat this disease. As a consequence a large number of compounds based on Hemicholinium (HC-3) have been described. Two compounds, previously reported to inhibit the human enzyme, have recently been shown to inhibit P. falciparum CK (PfCK) and therefore their potential applications might be anticipated to other pathogens. Herein, using molecular dynamic simulations, we have firstly observed that the ATP and the choline binding site of different CK in pathogens and human are conserved, suggesting that previous compounds inhibiting the human enzyme may also interact with CKs from different pathogens. We have substantiated such observation with experimental assays showing that HsCKα1, PfCK and CpCK bind to two compounds with distinct structural features in the low µM range. Collectively, these results uncover similarities among the choline kinase binding site from different pathogenic species and the human enzyme, highlighting the feasibility of designing novel inhibitors based on the choline binding pocket.
Assuntos
Antiprotozoários/química , Colina Quinase/antagonistas & inibidores , Inibidores Enzimáticos/química , Hemicolínio 3/análogos & derivados , Proteínas de Protozoários/antagonistas & inibidores , Trifosfato de Adenosina/química , Sequência de Aminoácidos , Antiprotozoários/síntese química , Antiprotozoários/farmacologia , Domínio Catalítico , Colina/química , Colina Quinase/química , Cryptosporidium parvum/efeitos dos fármacos , Cryptosporidium parvum/enzimologia , Cryptosporidium parvum/crescimento & desenvolvimento , Inibidores Enzimáticos/síntese química , Inibidores Enzimáticos/farmacologia , Hemicolínio 3/síntese química , Hemicolínio 3/farmacologia , Humanos , Concentração Inibidora 50 , Simulação de Dinâmica Molecular , Dados de Sequência Molecular , Plasmodium falciparum/efeitos dos fármacos , Plasmodium falciparum/enzimologia , Plasmodium falciparum/crescimento & desenvolvimento , Plasmodium knowlesi/efeitos dos fármacos , Plasmodium knowlesi/enzimologia , Plasmodium knowlesi/crescimento & desenvolvimento , Estrutura Secundária de Proteína , Proteínas de Protozoários/química , Homologia de Sequência de Aminoácidos , Especificidade da EspécieRESUMO
Necrobiosis lipoidica (NL) is a disease of collagen. Squamous cell carcinomas developing in areas of chronic ulceration and scarring have been well documented in a variety of skin diseases but rarely in areas of necrobiosis lipoidica. The case history of a 76-year-old female is presented, whose squamous cell carcinoma appeared 30 years after the diagnosis of necrobiosis lipoidica. The clinical and histopathological picture is described, stressing the importance of the unusual association of the two pathologies in the prognostic.
Assuntos
Carcinoma de Células Escamosas/complicações , Necrobiose Lipoídica/complicações , Neoplasias Cutâneas/complicações , Idoso , Carcinoma de Células Escamosas/patologia , Feminino , Humanos , Neoplasias Cutâneas/patologiaAssuntos
Infecções por Corynebacterium/complicações , Granuloma/microbiologia , Infecções por HIV/complicações , Dermatopatias Bacterianas/complicações , Adulto , Antibacterianos/uso terapêutico , Corynebacterium/isolamento & purificação , Infecções por Corynebacterium/tratamento farmacológico , Eritromicina/uso terapêutico , Granuloma/complicações , Granuloma/tratamento farmacológico , Humanos , Masculino , Dermatopatias Bacterianas/tratamento farmacológicoRESUMO
This study describes the effects of short- and long-term ethanol treatment and withdrawal on the biosynthesis of the phospholipids phosphatidylcholine (PC) and phosphatidylethanolamine (PE) in hepatocytes isolated from rats, using isotopically labelled choline and ethanolamine as exogenous precursors. Our results demonstrate that short-term ethanol consumption increases the incorporation of exogenous polar bases into PC and PE, whereas long-term ethanol administration provokes a differential effect in both PC and PE biosynthesis via cytidine diphosphate derivatives (CDP-derivatives), decreasing PC synthesis and increasing the biosynthesis of PE. We suggest that the increased biosynthesis of PE after ethanol treatment results from changes in lipogenic substrates produced as a consequence of ethanol metabolism, whilst the specific inhibition of PC biosynthesis seems to be a consequence of alterations of enzymes involved in the CDP-choline pathway. With regard to the influence of ethanol on PE methylation to give PC, our results demonstrate that ethanol activates this pathway in short-term, as well as chronic ethanol treatment. Ethanol withdrawal returns the activity of the PC and PE pathways to control levels. The alterations in the biosynthesis of the main phospholipids, PC and PE, demonstrated in this study could be of a great physiological interest in determining the pathology of alcoholism.
Assuntos
Etanol/farmacologia , Hepatócitos/metabolismo , Fígado/efeitos dos fármacos , Fosfatidilcolinas/biossíntese , Fosfatidiletanolaminas/biossíntese , Síndrome de Abstinência a Substâncias/metabolismo , Animais , Células Cultivadas , Dieta , Fígado/metabolismo , Masculino , Ratos , Ratos Sprague-Dawley , Fatores de TempoRESUMO
We have studied in vitro the effects of ethanol on the different enzymes involved in the biosynthesis of phosphatidylcholine (PC) via CDP-choline. Ethanol alters neither choline kinase (CK) nor CTP:phosphocholine cytidylyltransferase (CT) activities but, at levels higher than 50 mM, it does significantly inhibit microsomal cholinephosphotransferase (CPT) activity concomitantly with an increase in the ethanol concentration. A study of the kinetics of the reaction catalysed by CPT shows that ethanol decreases Vmax without altering Km, indicating a non-competitive inhibitory effect. An analysis of the thermodependence of CPT activity in the absence of ethanol reveals a break in the Arrhenius plot and thus a straight relationship between enzyme activity and the physico-chemical state of the microsomal membrane. Incubation of microsomes in the presence of ethanol increased the transition temperature from 25.8-28.2 degrees C. Microsomes were also incubated with n-alkanols with chain-lengths of fewer than five carbon atoms at concentrations which, according to their partition coefficients, produce equimolar levels in the membrane. Under these conditions all the alkanols caused the same inhibitory effect. All these results demonstrate that ethanol modulate the PC biosynthesis at the level of CPT activity and does not affect the CT enzyme. The inhibition found on CPT is clearly dependent on the alteration produced by ethanol on the hepatic microsomal membrane.
Assuntos
Citidina Difosfato Colina/metabolismo , Diacilglicerol Colinofosfotransferase/antagonistas & inibidores , Etanol/farmacologia , Fígado/metabolismo , Fosfatidilcolinas/biossíntese , Álcoois/farmacologia , Animais , Colina Quinase/metabolismo , Colina-Fosfato Citidililtransferase/metabolismo , Diacilglicerol Colinofosfotransferase/metabolismo , Cinética , Fígado/enzimologia , Masculino , Microssomos Hepáticos/enzimologia , Ratos , Ratos Sprague-Dawley , TemperaturaRESUMO
We isolated hepatocytes from rats chronically fed with ethanol and pair-fed control rats and incubated them both in the presence and absence of 100 mM ethanol in order to analyze the uptake into their lipids of several radiolabeled exogenous substrates. The hepatocytes treated chronically with ethanol showed higher lipogenic activity both in neutral lipids and phospholipids from serine, ethanolamine, glycerol and oleate. The only exception found was in the incorporation of choline into phosphatidylcholine (PC), which was lower in the hepatocytes from ethanol-fed rats than in the controls and was concomitant with a decrease in the PC levels of the ethanol-fed hepatocytes. The results obtained after exposing the cells to 100 mM ethanol in vitro indicate that in general the hepatocytes from ethanol-fed rats exhibit a higher lipogenic activity than the control cells. The only difference in the response to ethanol in vitro was found in the biosynthesis of phosphatidylserine (PS) from serine, which rose significantly in control cells but was unaffected in alcoholic hepatocytes. We put this difference in response down to specific adaptation to ethanol feeding.
Assuntos
Etanol/administração & dosagem , Hepatócitos/efeitos dos fármacos , Hepatócitos/metabolismo , Lipídeos/biossíntese , Animais , Ésteres do Colesterol/biossíntese , Colina/metabolismo , Diglicerídeos/biossíntese , Etanol/farmacologia , Etanolamina/metabolismo , Glicerol/metabolismo , Masculino , Ácido Oleico/metabolismo , Fosfatidilcolinas/biossíntese , Fosfatidiletanolaminas/biossíntese , Fosfatidilserinas/biossíntese , Fosfolipídeos/biossíntese , Ratos , Ratos Sprague-Dawley , Serina/metabolismo , Triglicerídeos/biossínteseRESUMO
We studied the incorporation of different radioactively labeled exogenous substrates into the lipids of rat hepatocytes previously incubated with ethanol. Glycerol, oleate, and serine were all incorporated into neutral lipids to a significantly greater degree in the presence of ethanol, the increase in radioactivity in the triacylglycerol fraction being quite substantial. A similar ethanol-induced increase was found in the incorporation of these substrates into the various phospholipids. This lipogenic activity did not occur when the metabolism of ethanol was blocked by 4-methylpyrazole, an inhibitor of hepatic ADH (alcohol:NAD+ oxidoreductase, EC 1.1.1.1) activity, thus demonstrating that one of the initial effects of ethanol on lipid biosynthesis was mediated by some products of its metabolism in the liver. The only alteration that persisted in the presence of 4-methylpyrazole was an inhibitory effect on the esterification of free cholesterol from oleate, suggesting that ethanol specifically inhibits hepatic ACAT (acyl CoA:cholesterol O-acyltransferase, EC 2.3.1.26) activity.
Assuntos
Etanol/farmacologia , Lipídeos/biossíntese , Fígado/efeitos dos fármacos , Oxirredutases do Álcool/antagonistas & inibidores , Animais , Fomepizol , Glicerol/química , Glicerol/farmacologia , Lipídeos/isolamento & purificação , Fígado/citologia , Fígado/metabolismo , Masculino , Ácido Oleico/química , Ácido Oleico/farmacologia , Fosfolipídeos/biossíntese , Fosfolipídeos/isolamento & purificação , Pirazóis/farmacologia , Ratos , Ratos Sprague-Dawley , Serina/química , Serina/farmacologiaRESUMO
In the present study, we investigated the possible mechanisms by which oxytocin might regulate oxytocin receptor (OTR) density. Exposure of cultured myometrial cells to oxytocin for a prolonged period caused desensitization: the steady-state level of oxytocin binding was 210 x 10(3) binding sites/cell, but this was time-dependently reduced to 20.1 x 10(3) sites/cell by exposing the cells to oxytocin for up to 20 h. In contrast, Western blotting data showed that the total amount of OTR protein was not affected by oxytocin treatment for up to 24 h. Flow cytometry experiments demonstrated that OTRs were not internalized during this treatment. However, RNase protection assays and Northern analysis showed that in cultured myometrial cells OTR mRNA was reduced by oxytocin treatment to reach a new low steady-state concentration. Analysis of this mRNA in myometrial biopsies from 17 patients undergoing emergency Caesarean section showed how it decreased with advancing labour. Samples obtained after 12 h of labour contained approximately 50 times less OTR mRNA than samples obtained from patients in labour for less than 12 h. We speculate that this decrease in OTR mRNA represents in-vivo OTR desensitization.
Assuntos
Regulação da Expressão Gênica , Trabalho de Parto/fisiologia , Miométrio/fisiologia , Ocitocina/fisiologia , Receptores de Ocitocina/fisiologia , Células Cultivadas , Cesárea , Regulação para Baixo , Feminino , Humanos , Cinética , Miométrio/citologia , Miométrio/patologia , Ocitocina/metabolismo , Ocitocina/farmacologia , Gravidez , Terceiro Trimestre da Gravidez , RNA Mensageiro/genética , Transcrição GênicaRESUMO
We have recently provided evidence for the desensitization of oxytocin receptors in human myometrial cells. In the present study, we have investigated the possible mechanisms by which oxytocin (OT) might regulate OT receptor density. The steady state level of OT binding in cultured myometrial cells was 220 x 10(3) binding sites/ cell, but this was time-dependently reduced to 27 x 10(3) sites/cell by exposure to OT for up to 20 h. Similarly, OT exposure decreased the binding of OT to cell membranes. In contrast, Western blotting data showed that the total amount of OT receptor protein was not affected by OT treatment for up to 48 h. Flow cytometry experiments demonstrated that OT receptors are not internalized during prolonged exposure of the cells to OT. However, RNase protection assays and Northern analysis showed that OT receptor mRNA was reduced by OT treatment to reach a new low steady state level with a time course similar to that of the disappearance of cell surface OT binding sites. Possible mechanisms involved in mRNA down-regulation include transcriptional suppression and destabilization of mRNA by RNA binding proteins.
Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Miométrio/efeitos dos fármacos , Ocitocina/farmacologia , RNA Mensageiro/metabolismo , Receptores de Ocitocina/efeitos dos fármacos , Northern Blotting , Western Blotting , Células Cultivadas , Regulação para Baixo , Feminino , Citometria de Fluxo , Humanos , Miométrio/metabolismo , Ocitocina/metabolismo , Gravidez , Ligação Proteica/efeitos dos fármacos , RNA Mensageiro/análise , Receptores de Ocitocina/genética , Receptores de Ocitocina/metabolismoRESUMO
Prostaglandin F2 alpha (PGF2 alpha) has regulatory (mainly luteolytic) effects in the ovary but the mechanism of action is not completely understood. Reverse transcriptase-polymerase chain reaction (RT-PCR) techniques were used to demonstrate the presence of mRNA encoding the PGF2 alpha receptor (FP receptor) in human granulosa-lutein cells. Specific primers for the amplification of cDNA were designed and yielded a single product of 696 bp corresponding to the FP receptor. The identity of this product was verified by sequencing. Fluprostenol, a selective FP receptor agonist, activated phospholipase C (PLC) and increased intracellular free calcium concentration, confirming the functional activation of the receptor. We have demonstrated by Western blotting that granulosa cells express PLC-beta and PLC-gamma isoforms. The cells responded to pervanadate with increased PLC activity and increased tyrosine phosphorylation, demonstrating a functional PLC-gamma tyrosine kinase pathway. However, fluprostenol did not provoke any detectable tyrosine phosphorylation. Moreover, the effect of fluprostenol was inhibited through protein kinase C stimulation by phorbol 12, 13-dibutyrate, and was not affected when cells were treated with phenylarsine oxide, which blocks tyrosine phosphorylation. These results suggest that the FP receptor activates PLC-beta rather than PLC-gamma isoforms. Fluprostenol-induced activation was pertussis toxin resistant. Granulosa cells express G proteins of the Gq family (resistant to pertussis toxin) and mRNA for both G alpha q and G alpha 1 l has been identified by RT-PCR. In conclusion, human granulosa cells have a functional FP receptor the effects of which are mediated through PLC-beta activation probably via Gq/1 l.
Assuntos
Dinoprosta/metabolismo , Células da Granulosa/metabolismo , Receptores de Prostaglandina/metabolismo , Cálcio/metabolismo , Células Cultivadas , Ativação Enzimática , Feminino , Proteínas de Ligação ao GTP/metabolismo , Humanos , Isoenzimas/metabolismo , Luteolíticos/farmacologia , Reação em Cadeia da Polimerase , Prostaglandinas F Sintéticas/farmacologia , RNA Mensageiro/análise , Receptores de Prostaglandina/genética , Fosfolipases Tipo C/metabolismoRESUMO
1. The aim of the present study was to investigate the effects of ethanol in vitro on the phospholipid biosynthetic pathways in hepatocytes isolated from the rat. We have used [methyl-14C]-choline, [1-3H]-ethanolamine and L-[3-3H]-serine as exogenous precursors of the corresponding phospholipids, phosphatidylcholine (PC), phosphatidylethanolamine (PE) and phosphatidylserine (PS). 2. Incubation of hepatocytes in the presence of ethanol significantly alters the incorporation of radiolabel from [14C]-choline and [3H]-ethanolamine into the metabolic intermediates and the final products of the CDP-choline and CDP-ethanolamine pathways. Radioactivity in the metabolic intermediates of both pathways was significantly decreased and the amount of label in PE was reduced whilst that of PC was not modified. 3. In the presence of 4-methylpyrazole, an inhibitor of alcohol dehydrogenase (ADH) activity, ethanol produces a reduction in the label of choline phosphate, ethanolamine phosphate and a significant decrease in the amount of PC and PE radiolabel. 4. On the other hand, ethanol increases the incorporation of serine into phosphatidylserine, phosphatidylethanolamine and phosphatidylcholine, although this effect is observed only in the absence of 4-methylpyrazole, indicating that this alteration is produced by some metabolite generated as a consequence of hepatic alcohol metabolism. 5. Ethanol also interferes with the methylation of phosphatidylethanolamine produced via the CDP-ethanolamine pathway but it does not alter phosphatidylethanolamine methylation when this phospholipid is produced by mitochondrial phosphatidylserine decarboxylation, suggesting the existence of different intramembrane pools of phosphatidylethanolamine, which may exhibit different sensitivity to alcohol. 6. Our results indicate that ethanol exerts two different effects on phospholipid metabolism in hepatocytes: a stimulatory effect on the incorporation of exogenous substrates into different phospholipids probably related to an alteration in the availability of lipogenic substrates as a consequence of ethanol metabolism, and another inhibitory effect produced by ethanol per se, which can be observed only when ethanol metabolism is inhibited by the presence of a specific inhibitor of alcohol dehydrogenase activity.
Assuntos
Etanol/farmacologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Fosfolipídeos/biossíntese , Álcool Desidrogenase/antagonistas & inibidores , Álcool Desidrogenase/metabolismo , Animais , Radioisótopos de Carbono , Células Cultivadas , Colina/análogos & derivados , Colina/metabolismo , Colina/farmacologia , Inibidores Enzimáticos/farmacologia , Etanolamina , Etanolaminas/metabolismo , Etanolaminas/farmacologia , Fomepizol , Masculino , Pirazóis/farmacologia , Ratos , Ratos Sprague-Dawley , Sensibilidade e Especificidade , Serina/metabolismo , Serina/farmacologia , TrítioRESUMO
Although a physiological role for oxytocin during parturition is well accepted, the mechanisms by which it activates myometrial contractility during labor have not been completely elucidated. We have previously shown the presence of Gq and two pertussis toxin (PT) substrates of the Gi family in human myometrial cells. In the present study, we have identified by Western blotting the G protein and phospholipase C (PLC) isoforms present in these cells and investigated their implication in oxytocin signaling by measuring the formation of inositol phosphates (IPs) and mobilization of intracellular calcium. We found G protein subunits alpha(q), alpha(11), alpha(i1), alpha(i2), alpha(i3), alpha(z), and two splice variants of alpha(s)- and beta-subunits. We have also detected the presence of five PLC isoforms: beta 1, beta 2, beta 3, gamma 1, and gamma 2. Oxytocin-induced IPs formation and intracellular Ca2+ mobilization were inhibited to approximately 50% after pretreatment of the cells with PT, suggesting that oxytocin activates PLC beta by interacting with at least two types of G proteins: a member of the Gq family (PT resistant) and a member of the Gi family (PT sensitive). The tyrosine phosphatase inhibitor pervanadate stimulated IPs formation in myometrial cells. Using the protein kinase inhibitors staurosporine, phenylarsine oxide, and Ro 31-8220 and the protein kinase C activator phorbol dibutyrate, we have shown that pervanadate and oxytocin activate PLC by different mechanisms. Furthermore, oxytocin did not activate tyrosine phosphorylation in human myometrial cells, as measured with an antiphosphotyrosine antibody, indicating that it does not activate a PLC gamma isoform. We conclude that oxytocin activates human myometrium by interacting with at least two G proteins and possibly three PLC beta isoforms.
Assuntos
Proteínas de Ligação ao GTP/metabolismo , Isoenzimas/metabolismo , Miométrio/metabolismo , Ocitocina/fisiologia , Transdução de Sinais , Fosfolipases Tipo C/metabolismo , Sequência de Aminoácidos , Western Blotting , Cálcio/metabolismo , Células Cultivadas , Ativação Enzimática , Feminino , Humanos , Soros Imunes/química , Membranas Intracelulares/metabolismo , Dados de Sequência Molecular , Miométrio/citologia , Concentração Osmolar , Peptídeos/imunologiaRESUMO
The objective of this study was to investigate the mechanism of action of PGF2 alpha in cultured human myometrial cells. We measured the effects of PGF2 alpha and fluprostenol, a selective PGF2 alpha receptor (FP receptor) agonist, on phospholipase C(PLC) activation, on changes in the intracellular free calcium concentration ([Ca2+]i), and on protein tyrosine phosphorylation. PGF2 alpha and fluprostenol activated PLC (determined by measuring the formation of inositol phosphates) and increased [Ca2+]i in a concentration-dependent manner. The apparent affinity of the FP receptor for fluprostenol was higher than that for PGF2 alpha when measuring PLC activation, but the receptor displayed similar affinities for both agonists when measuring increases in [Ca2+]i. These effects were not altered by treating the cells with pertussis toxin (PT), suggesting that the FP receptor is linked to PLC activation by a G protein of the Gq family. By contrast, the effect of oxytocin on PLC activation involved both PT-resistant and PT-sensitive pathways. Human myometrial cells responded to pervanadate and epidermal growth factor with increased PLC activity and increased tyrosine phosphorylation, demonstrating a functional PLC-gamma tyrosine kinase pathway. However, neither fluprostenol nor oxytocin stimulated tyrosine phosphorylation, but the effects of both agonists were inhibited after protein kinase C stimulation. These data suggest that fluprostenol and oxytocin activate PLC-beta rather than PLC-gamma isoforms. The effect of fluprostenol is Ca2+ dependent, but is unlikely to involve a direct effect of Ca2+ on PLC activity.
Assuntos
Cálcio/metabolismo , Miométrio/metabolismo , Prostaglandinas F Sintéticas/farmacologia , Fosfolipases Tipo C/metabolismo , Transporte Biológico , Células Cultivadas , Dinoprosta/farmacologia , Ativação Enzimática , Feminino , Humanos , Fosfatos de Inositol/biossíntese , Membranas Intracelulares/metabolismo , Miométrio/citologia , Concentração Osmolar , Toxina Pertussis , Fosforilação , Tirosina/metabolismo , Fatores de Virulência de Bordetella/farmacologiaRESUMO
We have studied the synthesis of phospholipids in hepatocytes isolated from chronically ethanol-treated rats by using isotopically labelled serine, ethanolamine, and choline as exogenous precursors. Our results demonstrate that ethanol induces specific effects on the biosynthesis of phosphatidylethanolamine and phosphatidylcholine via CDP-derivatives and also on the synthesis of phosphatidylserine via the Ca(++)-dependent base-exchange reaction. Thus, the synthesis of phosphatidylethanolamine from [3-H]ethanolamine and the incorporation of [3H]serine into phosphatidylserine were clearly higher in hepatocytes from ethanol-treated rats compared to controls. The synthesis of phosphatidylcholine from [methyl-14C]choline, on the other hand, decreased markedly, suggesting a specific inhibition of cholinephosphotransferase activity. We have also demonstrated that the phosphatidylcholine levels are markedly decreased in hepatocytes isolated from chronically ethanol-treated rats as a consequence of the lower phosphatidylcholine biosynthesis. The decrease in the incorporation of radioactivity from choline to betaine, which we also found, is interpreted as being the result of a higher use of betaine as methyl donor instead of methionine to maintain the hepatic S-adenosylmethionine levels in chronic alcoholism.
Assuntos
Alcoolismo/metabolismo , Colina/metabolismo , Etanolaminas/metabolismo , Fígado/metabolismo , Fosfolipídeos/biossíntese , Serina/metabolismo , Animais , Radioisótopos de Carbono , Células Cultivadas , Diacilglicerol Colinofosfotransferase/antagonistas & inibidores , Diacilglicerol Colinofosfotransferase/metabolismo , Etanolamina , Masculino , Fosfatidilcolinas/biossíntese , Fosfatidiletanolaminas/biossíntese , Fosfatidilserinas/biossíntese , Técnica de Diluição de Radioisótopos , Ratos , Ratos Sprague-Dawley , Valores de Referência , TrítioRESUMO
Results demonstrate for the first time that ethanol exerts two different effects on the lipid order of chick-liver mitochondria and microsomes: a fluidizing effect both in the core and at the surface of the membrane, which depends on its physical presence, and a rigidization of the surface of these membranes which occurs after its removal. In addition, and directly related to the reduction in fluidity produced in the membrane surface after ethanol removal, we have detected a persistent alteration in different enzyme activities involved in the hepatic mitochondrial and microsomal electron-transport systems. The persistence of the alterations in the lipid order and enzyme activities may result from a structural rearrangement of the lipid and protein components produced in the lipid bilayer surface when ethanol is no longer present in the membrane.
Assuntos
Etanol/farmacologia , Metabolismo dos Lipídeos , Fígado/metabolismo , Animais , Embrião de Galinha , Transporte de Elétrons/efeitos dos fármacos , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Corantes Fluorescentes , Fígado/efeitos dos fármacos , Fígado/enzimologia , Fluidez de Membrana/efeitos dos fármacos , Membranas/efeitos dos fármacos , Membranas/enzimologia , Membranas/metabolismo , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Mitocôndrias Hepáticas/efeitos dos fármacos , Mitocôndrias Hepáticas/enzimologia , NADH Desidrogenase/metabolismo , Frações Subcelulares/efeitos dos fármacos , Frações Subcelulares/enzimologiaRESUMO
A physiological role for oxytocin in stimulating uterine contractions during labour is well accepted, but has not yet been well defined. Oxytocin activates phospholipase C to produce inositol 1,4,5-trisphosphate, which releases Ca2+ from intracellular stores. There is considerable evidence that G-proteins are involved in this signalling pathway. The objectives of the present study were to determine the mechanisms of action of oxytocin in human myometrium. We have measured the effect of oxytocin on the formation of inositol phosphates (InsPs) in cultured human myometrial cells labelled with [3H] inositol and on changes in intracellular free Ca2+ concentration ([Ca2+i]) in single cells using a dynamic calcium imaging system. Pertussis toxin was used to obtain information on the G-proteins involved. Oxytocin induced InsPs formation and [Ca2+i] mobilisation in a concentration-dependent manner in human myometrial cells. Our data suggest that two distinct types of G-proteins are involved in the oxytocin response: one most probably a member of the Gq family (pertussis toxin-resistant) and another of the Gi family (pertussis toxin-sensitive). Using Western blotting, we have found that the pertussis toxin-resistant G-proteins alpha(q), alpha(11) and alpha(2), and pertussis toxin-sensitive alpha(i1), alpha(i2), and alpha(i3) are expressed in these cells. We have also detected the phospholipase C isoforms beta(1), beta(2) and beta(3) which are regulated by G-proteins, and phospholipase C isoforms gamma(1) and gamma(2), regulated by receptor tyrosine kinase pathways. However, oxytocin does not stimulate tyrosine phosphorylation in myometrial cells. Extracellular Ca2+ does not play a direct role in the activation of phospholipase C by oxytocin. Protein kinase C causes a strong inhibitory feedback on the oxytocin pathway: protein kinase C activators abolish the response to oxytocin while inhibitors potentiate it. Oxytocin responsiveness is upregulated by incubating the cells in the presence of oestradiol. This effect is reversed by the anti-oestrogen tamoxifen. Oestrogens exert their effects on the oxytocin pathway at a postreceptor level, possibly by affecting the expression of G-proteins and/or phospholipase C isoforms.